Levetiracetam Tablet, Film Coated
Product Images NDC 67877-770

12 FDA label images from Ascend Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 67877-770). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Leve-stru (Leve Stru)

Leve-stru (Leve Stru)
Chemical structure diagram of the active ingredient Levetiracetam, showing its molecular framework including a pyrrolidone ring and various side groups.*
FDA Label Image

Leve-fig-1 (Leve Fig 1)

Leve-fig-1 (Leve Fig 1)
A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The chart shows increasing patient response percentages from placebo at 7.4%, Levetiracetam 1000 mg/day at 37.1%, to Levetiracetam 3000 mg/day at 39.6%.*
FDA Label Image

Leve-fig-2 (Leve Fig 2)

Leve-fig-2 (Leve Fig 2)
Bar chart depicting the percentage of patients experiencing an outcome across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The vertical axis shows percentage of patients, with Levetiracetam groups showing higher percentages than placebo.*
FDA Label Image

Leve-fig-3 (Leve Fig 3)

Leve-fig-3 (Leve Fig 3)
A bar chart comparing the percentage of patients between two groups: Placebo (104 patients) at 14.4%, and Levetiracetam 3000 mg/day (180 patients) at 39.4%. The vertical axis represents the percentage of patients, ranging from 0% to 45%. The chart illustrates a higher patient percentage for the Levetiracetam group compared to placebo.*
FDA Label Image

Leve-fig-4 (Leve Fig 4)

Leve-fig-4 (Leve Fig 4)
A bar chart comparing the percentage of patients between placebo and levetiracetam groups. The placebo group (N=97) shows 19.6% of patients, while the levetiracetam group (N=101) shows 44.6% of patients, indicating a higher percentage with levetiracetam.*
FDA Label Image

Leve-fig-5 (Leve Fig 5)

Leve-fig-5 (Leve Fig 5)
A bar chart comparing the percentage of patients in two groups: Placebo (N=51) and Levetiracetam (N=58). The vertical axis shows the percentage of patients ranging from 0% to 45%. The Levetiracetam group has a higher percentage (43.1%) than the Placebo group (19.6%).*
FDA Label Image

Leve-fig-6 (Leve Fig 6)

Leve-fig-6 (Leve Fig 6)
A bar chart comparing the percentage of patients between two groups: Placebo (N=84) and Levetiracetam (N=79). The Levetiracetam group shows a higher percentage at 72.2%, while the Placebo group shows 45.2%. The y-axis represents the percentage of patients from 0% to 100%.*
FDA Label Image

Levetiracetam-tabs-250mg-500tabs (Levetiracetam Tabs 250mg 500tabs)

Levetiracetam-tabs-250mg-500tabs (Levetiracetam Tabs 250mg 500tabs)
Label for Levetiracetam Tablets, USP 250 mg, film-coated oral tablets. The label indicates a package size of 500 tablets, with warnings for pharmacists to dispense the accompanying medication guide. Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC. Storage instructions include keeping the product between 20°C to 25°C. The label also shows the NDC 67877-768-05 and includes a barcode.*
FDA Label Image

Levetiracetam-tabs-500mg-120tabs (Levetiracetam Tabs 500mg 120tabs)

Levetiracetam-tabs-500mg-120tabs (Levetiracetam Tabs 500mg 120tabs)
Label for Levetiracetam Tablets, USP 500 mg film-coated oral tablets by Ascend Laboratories, LLC. Contains 120 tablets. Includes pharmacist dispensing instructions, storage conditions, manufacturer and distributor information, and a barcode. The label features the Ascend Laboratories logo and NDC number 67877-769-12.*
FDA Label Image

Levetiracetam-tabs-750mg-500tabs (Levetiracetam Tabs 750mg 500tabs)

Levetiracetam-tabs-750mg-500tabs (Levetiracetam Tabs 750mg 500tabs)
Label for Levetiracetam Tablets, USP 750 mg, film-coated tablets for oral use. The label indicates 500 tablets per container, manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC. It includes instructions for pharmacists to dispense the medication guide, storage conditions, and dosage information references. The label features the Ascend Laboratories logo and a barcode.*
FDA Label Image

Levetiracetam-tabs-1000mg-60tabs (Levetiracetam Tabs 1000mg 60tabs)

Levetiracetam-tabs-1000mg-60tabs (Levetiracetam Tabs 1000mg 60tabs)
Levetiracetam Tablets USP 1000 mg film-coated oral tablets label showing pharmacist dispensing instructions, storage conditions, and manufacturer Alkem Laboratories, India. Distributed by Ascend Laboratories, LLC with NDC 67877-771-60. The label indicates a package of 60 tablets and includes a barcode and a note about UV varnish on part of the label.*
FDA Label Image

Levetiracetam-500mg-cart (Levetiracetam 500mg Cart)

Levetiracetam-500mg-cart (Levetiracetam 500mg Cart)
Box packaging label for Levetiracetam Tablets, USP 500 mg, film-coated oral tablets by Ascend Laboratories, LLC. Contains 100 tablets (10x10 unit-dose). Includes pharmacist dispensing instructions, storage conditions, and manufacturer details (Alkem Laboratories Ltd., India). Features NDC 67877-769-38 and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.